Di Sun

发表

A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Clinical cardiology.

Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia.

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Atherosclerosis.

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Diabetes Care.

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Lipids in Health and Disease.

Lipoprotein (a) as a Marker for Predicting the Presence and Severity of Coronary Artery Disease in Untreated Chinese Patients Undergoing Coronary Angiography.

Yuan-Lin Guo, P. Qing, N. Wu, 2018, Biomedical and environmental sciences : BES.

Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, JACC. Asia.

Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation

Cheng-gang Zhu, Yunshan Cao, Yuan-Lin Guo, 2018, Lipids in Health and Disease.

The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2018, Atherosclerosis.

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

Jian Li, Yuan-Lin Guo, N. Wu, 2019, Journal of Translational Medicine.

Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Personalized medicine.

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Journal of Translational Medicine.

Impacts of Prediabetes Mellitus Alone or Plus Hypertension on the Coronary Severity and Cardiovascular Outcomes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Hypertension.

Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease.

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Journal of thoracic disease.

Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study.

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Heart, lung & circulation.

Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Journal of clinical laboratory analysis.

Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case-control study.

Yuan-Lin Guo, P. Qing, N. Wu, 2018, Metabolism: clinical and experimental.

High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease.

Yuan-Lin Guo, P. Qing, N. Wu, 2017, Atherosclerosis.

High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Hypertension Research.

Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Annals of medicine.

Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Gelsolin deposits in renal tissues of the patients with lupus nephritis

B. Liu, D. Guo, D. Sun, 2016 .

Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation

Yunshan Cao, Yuan-Lin Guo, N. Wu, 2018, Lipids in Health and Disease.

Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2019, Clinical and translational gastroenterology.

A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Molecular Diagnosis & Therapy.

Familial hypercholesterolemia in very young myocardial infarction

Xiao-lin Li, Yuan-Lin Guo, P. Qing, 2018, Scientific Reports.

Increased Serum Leptin Levels in New-Onset, Untreated Female Patients with Coronary Artery Disease and Positively Associated with Inflammatory Markers

Cheng-gang Zhu, Yuan-Lin Guo, P. Qing, 2018, Annals of Nutrition and Metabolism.

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Journal of Translational Medicine.

Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia.

R. Santos, Yuan-Lin Guo, N. Wu, 2019, European journal of preventive cardiology.